Total revenue for the year ended June 30 was $6.9 billion, up from $5.8 billion the previous year, while total expenses increased from $5.4 billion in 2021 to $6.6 billion in 2022.
During the same period, salaries and related costs increased 20.3 percent year over year to $3.3 billion. Supply costs increased 29 percent year over year to $2.3 billion.
The five-hospital system reported $437.5 million in investment losses for the year ended June 30, down from a gain of $589.7 million the previous year, resulting in a net profit of $317.9 million, down from $1.1 billion the year prior.
However, Cedars-Sinai could see a significant capital boost in the third quarter. If Merck completes its $10.8 billion acquisition of Prometheus Biosciences, the health system — a shareholder in the pharma company — could receive $800 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
